Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended June 30, 2006, for Croff Enterprises, Inc. (Note: The input metadata listed "Therapeuticsmd, Inc.", but the filing text explicitly identifies the registrant as Croff Enterprises, Inc., an independent oil and natural gas exploration and production company). The company operates primarily through the acquisition of producing leases and ownership of mineral interests, with no control over production rates or market prices. As of August 1, 2006, there were 551,344 shares of common stock outstanding.
Key Financial Metrics
| Metric | Six Months Ended June 30, 2006 | Six Months Ended June 30, 2005 |
|---|---|---|
| Total Revenues | $448,985 | $398,596 |
| Oil and Natural Gas Sales | $435,106 | $379,986 |
| Net Income | $136,123 | $85,508 |
| Net Income Applicable to Common Shares | $4,032 | $(35,633) |
| Operating Cash Flow | $127,072 | $114,637 |
| Cash and Cash Equivalents (End of Period) | $778,254 | $418,442 |
| Total Assets | $1,690,220 | $1,807,502 |
| Working Capital | $738,946 | $625,862 |
| Debt | $0 | $0 |
Material Changes vs. Prior Period
- Revenue Growth: Total revenues increased 12% year-over-year, driven by a 14% increase in oil and natural gas sales. This was attributed to higher commodity prices (oil prices approx. $10/barrel higher; natural gas approx. $5.50/Mcf) and slightly increased production levels.
- Profitability: Net income increased 59% to $136,123. The improvement was primarily due to higher revenues and a 25% reduction in lease operating expenses ($123,158 vs. $162,763). The prior year included a $52,638 write-off of the Helen Gips well, which did not recur.
- Expense Management: Lease operating expenses decreased significantly due to lower workover costs and the absence of the prior year's write-off. General and administrative expenses increased slightly ($113,475 vs. $86,344) due to higher audit and professional fees.
- Asset Sales: The company received a $100,000 deposit on the sale of assets during the period. Subsequent to the quarter end, the company sold significant assets in the Yorktown drilling program for $255,000.
Outlook, Risks, and Management Commentary
- Liquidity: The company maintains a strong liquidity position with a current ratio of approximately 5:1 and no short-term or long-term debt. Management believes cash on hand and operating cash flows will cover working capital requirements for the next 12 months.
- Strategic Alternatives: The company continues to seek strategic alternatives to enhance shareholder value and liquidity. Negotiations are ongoing, but success is not assured.
- Market Risk: The company is highly exposed to fluctuations in crude oil and natural gas prices. A 10% reduction in prices would have reduced revenues by approximately $44,000 for the six-month period.
- Future Capital: Future capital expenditures depend on securing acceptable financing and reasonably priced opportunities. The company plans to utilize internal cash flows and potentially bank borrowings for its 2006 capital budget.
- Subsequent Events: On July 22, 2006, the company reported the sale of Yorktown program assets for $255,000. Additionally, a change in Corporate Secretary occurred in August 2006.
Key Facts for Investor Verification
- Entity Name Discrepancy: Verify the correct registrant name is Croff Enterprises, Inc., despite metadata suggesting Therapeuticsmd, Inc.
- Preferred Stock Dilution: Net income applicable to common shares is minimal ($4,032) compared to total net income ($136,123) due to significant allocations to Preferred B shares ($132,091).
- Asset Sale Completion: Confirm the final closing details and net proceeds of the Yorktown program asset sale reported as a subsequent event.
- Strategic Negotiations: Monitor the status of ongoing negotiations for strategic alternatives, as the company has no assurance of success.
- Commodity Price Sensitivity: Assess the impact of current oil and natural gas price volatility on future cash flows, given the company's lack of hedging mentioned in the text.